Alison Kodjak
-
An interdisciplinary team in San Francisco uses acupressure, massage, counseling and other methods, as well as medicine, to help kids get relief from chronic pain. But such pediatric centers are rare. -
A former official in the civil rights office says the unit seems afraid to offend U.S. Customs and Border Protection and ICE. Meanwhile, the complaints of abuses of families continue to pile up. -
Certain high-cost drugs are straining state budgets. A new deal approved Wednesday allows Louisiana to spend a fixed amount for unlimited access to a costly cure. Other states may try to follow suit. -
A quirk in the law gives an older opioid addiction treatment "orphan drug" status — and a period of exclusive market access. That may prevent some new therapies from reaching patients for years. -
A federal agency issued a proposed rule Friday that rolls back Obama-era protections for transgender patients. Advocates for transgender people say the rule leaves them vulnerable to discrimination. -
The Trump administration is revamping a rule governing discrimination in health-care setting, giving more leeway to providers who object to certain procedures for religious or conscience reasons.
-
The rule strengthens protections for health care providers who are unwilling to provide services like abortions. Critics say it could put women's health in danger. -
Several 2020 Democratic candidates support Medicare for All, but what would that proposal look like in action?
-
The Senate Finance Committee will hear Tuesday from executives from the biggest pharmacy benefit managers. Confidential rebates paid to the PBMs are expected to draw scrutiny. -
As congressional lawmakers continue to turn up the heat on drugmakers, insurers and middlemen over the price of many medicines, one player says it will limit patients' share of the cost of insulin.
